Fortenberry
James D. Fortenberry, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20100288703 | Novel Fluid Management System for Accurate Continuous Hemofiltration in Extracorporeal Membrane Oxygenation (ECMO) - A novel system and method for fluid management for accurate continuous venovenous hemofiltration (CWH) in extracorporeal membrane oxygenation (ECMO). The fluid management or CWH system is automated and configured for operation as a stand alone unit and can be easily integrated with an ECMO system. The fluid management system is capable of producing either perfect or negative fluid balance between ultrafiltrate removal and replacement fluid delivery. The fluid management system can achieve electrolyte replacement over a range of flow rates needed to care for patients ranging from neonates to adults. Finally, the novel fluid management system preserves patient safety, maintains sterility during operation, is easy to operate, and is compact enough to fit near a patient's bed. | 11-18-2010 |
Rance M. Fortenberry, Cazadero, CA US
Patent application number | Description | Published |
---|---|---|
20110170313 | LIGHT SOURCE ASSEMBLIES - A light source assembly comprises a light pipe, a first color light source at a first tapered light collector, a second light source at a second tapered light collector, and at least a first dichroic filter operative to pass first color light and to reflect second color light toward a light output port. A light valve may be positioned to receive light from the light pipe. One or more light entrances to the light pipe may have a filter, e.g., a short wave pass filter, oriented in a plane generally parallel to the axial optical pathway. | 07-14-2011 |
Robert S. Fortenberry, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20080252619 | System for Providing a Frustrated Total Internal Reflection Touch Interface - A system for providing a touch interface on a display are described. The system include providing an emitter on a first side of the display and providing a detector on a second side of the display. The emitter provides an electromagnetic signal to the display. The electromagnetic signal has a path from the emitter to the detector through the display in the absence of a user's touch such that the electromagnetic signal is detected by the detector in the absence of the user's touch. The path includes at least one total internal reflection in the display. The emitter and the detector are configured such that the user's touch at any of the at least one total internal reflection alters the path such that a portion of the electromagnetic signal does not reach the detector. | 10-16-2008 |
Yolanda Fortenberry, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20160130585 | APTAMERS FOR THE TREATMENT OF SICKLE CELL DISEASE - The present invention provides polynucleotide aptamers that selectively bind to and inhibit polymerization of sickle hemoglobin (HbS), pharmaceutical compositions comprising the same, methods of use for diagnostics and treatment of sickle cell disease, methods of use as capture reagents, and methods of rational drug design. | 05-12-2016 |